- Home
- SLS vs OPP Comparison
SLS vs OPP Comparison
Compare SLS & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- OPP
- Stock Information
- Founded
- SLS 2012
- OPP 2010
- Country
- SLS United States
- OPP United States
- Employees
- SLS N/A
- OPP N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- OPP Finance/Investors Services
- Sector
- SLS Health Care
- OPP Finance
- Exchange
- SLS Nasdaq
- OPP Nasdaq
- Market Cap
- SLS 185.3M
- OPP 208.6M
- IPO Year
- SLS N/A
- OPP N/A
- Fundamental
- Price
- SLS $1.69
- OPP $8.61
- Analyst Decision
- SLS Strong Buy
- OPP
- Analyst Count
- SLS 1
- OPP 0
- Target Price
- SLS $7.00
- OPP N/A
- AVG Volume (30 Days)
- SLS 2.0M
- OPP 108.0K
- Earning Date
- SLS 11-12-2025
- OPP 01-01-0001
- Dividend Yield
- SLS N/A
- OPP 14.41%
- EPS Growth
- SLS N/A
- OPP N/A
- EPS
- SLS N/A
- OPP N/A
- Revenue
- SLS N/A
- OPP N/A
- Revenue This Year
- SLS N/A
- OPP N/A
- Revenue Next Year
- SLS N/A
- OPP N/A
- P/E Ratio
- SLS N/A
- OPP N/A
- Revenue Growth
- SLS N/A
- OPP N/A
- 52 Week Low
- SLS $0.77
- OPP $7.26
- 52 Week High
- SLS $2.27
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- SLS 42.73
- OPP 42.64
- Support Level
- SLS $1.65
- OPP $8.70
- Resistance Level
- SLS $2.01
- OPP $8.78
- Average True Range (ATR)
- SLS 0.11
- OPP 0.07
- MACD
- SLS -0.02
- OPP -0.02
- Stochastic Oscillator
- SLS 11.11
- OPP 16.83
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.